Breath as a Biomarker Matrix: A Case Study in Liver Disease
A webinar to introduce how breath analysis can be used to gain a deeper understanding and earlier diagnosis of liver disease.
Please complete the form at the end of this page to view the webinar.
Watch this webinar ‘Breath as a Biomarker Matrix: A Case Study in Liver Disease’ on demand. Hosted by Owlstone Medical’s Lead Translational Scientist Dr. Giuseppe Ferrandino and Head of Business Development, Research Products & Services, Europe & RoW, Dr. Elizabeth Crone. We will introduce how breath analysis can be used to gain a deeper understanding and earlier diagnosis of liver disease.
Breath analysis has many unique advantages that can be useful in microbiome research. One key application is in measuring volatile microbial metabolites in different disease contexts including liver disease. Volatile metabolites can then travel through blood circulation to the lungs where they readily volatilize into air, and are subsequently exhaled. Several case studies will be covered, as well as the possibilities for at-home breath collection and analysis for decentralized clinical trial designs, and improved diagnostic tools.
This webinar is for researchers interested in exploring the use of non-invasive breath biomarkers in relation to liver disease, and anyone with an interest in learning more about the potential of breath research for clinical practice.